Point72 Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Point72 Asset Management's PFE Position: Q1 2026 in Review
Point72 Asset Management increased its Pfizer (PFE) stake by 32% in Q1 2026, buying an estimated $28.2M and bringing the position to 4,365,063 shares worth $123M. The position accounts for 0.16% of the portfolio, ranked #133.
Point72 Asset Management first reported a position in PFE in Q3 2014 and has held it in 12 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Point72 Asset Management held 4,365,063 shares of Pfizer worth $123M as of Q1 2026.
- Point72 Asset Management bought 1,059,371 Pfizer shares in Q1 2026, an estimated $28.2M.
- Pfizer made up 0.16% of Point72 Asset Management's portfolio in Q1 2026, its #133 holding.
- Point72 Asset Management first reported a position in Pfizer in Q3 2014 and has held it in 12 quarters since.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.